SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-12-001243
Filing Date
2012-02-22
Accepted
2012-02-22 06:26:15
Documents
13
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2207421z10-k.htm 10-K 1196883
2 EX-10.6.4 a2207421zex-10_64.htm EX-10.6.4 65961
3 EX-23.1 a2207421zex-23_1.htm EX-23.1 4176
4 EX-31.1 a2207421zex-31_1.htm EX-31.1 7923
5 EX-31.2 a2207421zex-31_2.htm EX-31.2 7961
6 EX-32.1 a2207421zex-32_1.htm EX-32.1 4892
13 G434273.JPG g434273.jpg GRAPHIC 71345
  Complete submission text file 0001047469-12-001243.txt   3823362

Data Files

Seq Description Document Type Size
7 EX-101.INS snta-20111231.xml EX-101.INS 429644
8 EX-101.SCH snta-20111231.xsd EX-101.SCH 17059
9 EX-101.CAL snta-20111231_cal.xml EX-101.CAL 47212
10 EX-101.DEF snta-20111231_def.xml EX-101.DEF 77484
11 EX-101.LAB snta-20111231_lab.xml EX-101.LAB 261536
12 EX-101.PRE snta-20111231_pre.xml EX-101.PRE 124400
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33277 | Film No.: 12628667
SIC: 2834 Pharmaceutical Preparations